IT1270647B - Solutions for the treatment of states of shock, in particular haemorrhagic shock - Google Patents

Solutions for the treatment of states of shock, in particular haemorrhagic shock

Info

Publication number
IT1270647B
IT1270647B ITMI942068A ITMI942068A IT1270647B IT 1270647 B IT1270647 B IT 1270647B IT MI942068 A ITMI942068 A IT MI942068A IT MI942068 A ITMI942068 A IT MI942068A IT 1270647 B IT1270647 B IT 1270647B
Authority
IT
Italy
Prior art keywords
shock
treatment
solutions
states
haemorrhagic
Prior art date
Application number
ITMI942068A
Other languages
Italian (it)
Inventor
Osvaldo Chiara
Giorgio Graziani
Original Assignee
Bieffe Medital Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bieffe Medital Spa filed Critical Bieffe Medital Spa
Priority to ITMI942068A priority Critical patent/IT1270647B/en
Publication of ITMI942068A0 publication Critical patent/ITMI942068A0/en
Publication of ITMI942068A1 publication Critical patent/ITMI942068A1/en
Application granted granted Critical
Publication of IT1270647B publication Critical patent/IT1270647B/en

Links

Landscapes

  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Hypertonic aqueous solutions for the first aid treatment of shock conditions, in particular haemorrhagic shock, containing sodium chloride and dextran, characterized in that they comprise: from 5 to 10% and preferably from 6 to 8% sodium chloride, from 3 to 10% and preferably from 5 to 7% of dextran having a molecular weight of 40,000 to 70,000, from 30 to 60 and preferably from 40 to 50 mmol/l of sodium bicarbonate, and from 0.3 to 3 and preferably from 1 to 2 mmol/l of allopurinol. <IMAGE>
ITMI942068A 1994-10-11 1994-10-11 Solutions for the treatment of states of shock, in particular haemorrhagic shock IT1270647B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITMI942068A IT1270647B (en) 1994-10-11 1994-10-11 Solutions for the treatment of states of shock, in particular haemorrhagic shock

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI942068A IT1270647B (en) 1994-10-11 1994-10-11 Solutions for the treatment of states of shock, in particular haemorrhagic shock

Publications (3)

Publication Number Publication Date
ITMI942068A0 ITMI942068A0 (en) 1994-10-11
ITMI942068A1 ITMI942068A1 (en) 1996-04-11
IT1270647B true IT1270647B (en) 1997-05-07

Family

ID=11369687

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI942068A IT1270647B (en) 1994-10-11 1994-10-11 Solutions for the treatment of states of shock, in particular haemorrhagic shock

Country Status (1)

Country Link
IT (1) IT1270647B (en)

Also Published As

Publication number Publication date
ITMI942068A0 (en) 1994-10-11
ITMI942068A1 (en) 1996-04-11

Similar Documents

Publication Publication Date Title
PH31652A (en) Dihydrolipoic acid as ophthalmological agent to suppress intolerable reactions in the aea between implants and living body tissue.
ZA898824B (en) Aqueous ophthalmic solutions and method for preserving same
EP0927038A4 (en) P1, p4-dithio-p2,p3-monochloromethylene 5&#39;, 5&#39;&#39;&#39;-diadenosine p1, p4-tetraphosphate as antithrombotic agent
CA2008762A1 (en) High salt content rapid disinfection solution for contact lenses
IT1270647B (en) Solutions for the treatment of states of shock, in particular haemorrhagic shock
FR2691708B1 (en) BIS-DITHIOPHOSPHORIC ACID DERIVATIVES AS ADDITIVES IN LUBRICANTS.
CA2198852A1 (en) Parenteral solutions containing 7-halo-1,2,3,4-tetrahydro-3-aryl-6-quinazoline sulfonamides
CA2020209A1 (en) Low viscosity, highly concentrated surfactant suspension
CA2129043A1 (en) Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine for the treatment of pain and oedema
GB9216506D0 (en) Improvements in or relating to the treatment of sickle cell disease
FR2718923B1 (en) Disinfecting composition in aqueous solution containing orthophthalaldehyde.
USD387665S (en) Water cooler casing
CA2193405A1 (en) Eyewash intended in particular for the treatment of the dry eye syndrome
ZA91614B (en) Agent for use in the prevention,control or reversal of hypertension
FR2690330B1 (en) DEVICE FOR TREATING CERTAIN FRACTURES LOCATED BETWEEN TROCHANTERIAL MASSIF AND 1/3 OF THE FEMALE DIAPHYSIS.
RU97108005A (en) EYE DROPS &#34;BALARPAN&#34;
Cook Sex role orientations and perceived parenting effectiveness
AU3274497A (en) Hot-water extract of seaweed of the family spermatochnaceae and use thereof
FR2715025B1 (en) Oyster pocket.
TJ288R3 (en) 1,3,5,-Oxadiazin derivative or its tautomer in free form or in form of salt containing its insecticidal agent
ITMI942076A0 (en) PROCEDURE FOR THE REDUCTION OF NICOTINE CONTENT THROUGH THE ACTION OF MICROORGANISMS
RU97116928A (en) CLEANSING TOOL FOR THE BODY AND FACE &#34;ATLAS LEATHER&#34;
BG103211U (en) Desensitive toothpaste
FR2762212B1 (en) POTENTIALIZING THE EFFECT OF PHOTOACTIVE AGENTS BY BUTYRATE AND ITS DERIVATIVES
RU97113900A (en) COMPOSITION FOR PREVENTION AND TREATMENT OF DENTAL CARIES

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970902